4157 |
北城證券研發部提供 非經同意不得轉載 本刊內容僅供參考 投資人應謹慎考量投資風險 本公司不負任何法律責任 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
4157 太景*-KY |
實收資本額 |
21 (百萬) |
|
|
|
|
|
|
|
|
|
市 場
別 |
OTC |
上 櫃 日 期 |
2014/01/17 |
|
|
|
|
|
|
|
|
|
發 言
人 |
黃國龍 |
電 話 |
281777020 |
|
|
|
|
|
|
|
|
|
地 址 |
中華民國台灣台北市內湖區新明路138號7樓 |
|
|
|
|
|
|
|
|
|
產 業
別 |
傳產-生技 |
|
|
|
|
|
|
|
|
|
主要產品 |
新藥研發 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
2025/5/2 股價 |
10.15 |
法人買賣超合計(近一日) |
買超 12.957 張 |
|
|
|
|
|
|
|
|
|
2025/5/2
漲跌 |
0.15
|
法人買賣超合計(近一週) |
買超
521.39 張 |
|
|
|
|
|
|
|
|
|
2025/5/2
漲跌幅 |
1.50
|
法人買賣超合計(近一月) |
買超
1644.09 張 |
|
|
|
|
|
|
|
|
|
券 資 比 |
0.93
|
外資連8買 |
|
自營連2賣 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
最新股利發放 |
股東會日期 |
現金股利(元) |
股票股利(元) |
除權日 |
除息日 |
殖利率 |
|
|
|
|
|
|
|
2023/05/26 |
#N/A |
#N/A |
#N/A |
#N/A |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
股利年度 |
股東會日期 |
現金股利(元) |
股票股利(元) |
除權日 |
除息日 |
扣抵率(%) |
殖利率 |
股利殖利率 |
現金殖利率 |
|
|
|
|
2024 |
2025/05/23 |
0.00 |
0.00 |
|
|
|
0% |
0% |
0% |
|
|
|
|
2023 |
2024/05/29 |
0.00 |
0.00 |
|
|
|
0% |
0% |
0% |
|
|
|
|
2022 |
2023/05/26 |
0.00 |
0.00 |
|
|
|
0% |
0% |
0% |
|
|
|
|
2021 |
2022/05/30 |
0.00 |
0.00 |
|
|
|
0% |
0% |
0% |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
機構估稅後EPS |
0.00 |
K(9) |
87.01 |
|
技術面 |
技術面 |
基本面 |
基本面 |
籌碼面 |
|
|
|
|
淨值(元) |
1.51 |
D(9) |
77.13 |
評分表 |
(短線) |
(中長線) |
(安全性) |
(成長性) |
|
|
|
|
預估本益比 |
|
周K(9) |
40.59 |
|
0 |
0 |
0 |
0 |
0 |
|
|
|
|
股價淨值比 |
6.72 |
周D(9) |
34.88 |
綜合評分: |
0 |
建議: |
不列入追踪 |
目標價: |
0 |
|
|
|
|
月線乖離率 |
7.14 |
季線乖離率 |
-5.44 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
2025/4/2 |
2025/4/11 |
2025/4/18 |
2025/4/25 |
2025/5/2 |
20*PE |
|
3*PB |
1,522.50 |
|
|
|
|
股價 |
10.75 |
9.15 |
9.58 |
9.52 |
10.15 |
15*PE |
|
2*PB |
1,015.00 |
|
|
|
|
成交量(千股) |
2,006 |
8,753 |
2,722 |
1,859 |
2,535 |
10*PE |
|
1*PB |
507.50 |
|
|
|
|
資餘 |
7,166 |
5,559 |
5,667 |
5,531 |
5,493 |
5*PE |
|
0.5*PB |
253.75 |
|
|
|
|
券餘 |
50 |
51 |
51 |
51 |
51 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
季IFRS財報(損益單季) |
202501 |
202404 |
202403 |
202402 |
202401 |
202304 |
202303 |
202302 |
|
|
|
|
營業收入淨額(千) |
|
10,489
|
8,611
|
121,487
|
10,064
|
8,592
|
9,311
|
99,469
|
|
|
|
|
營業成本(千) |
|
4,366
|
3,930
|
4,113
|
3,723
|
2,037
|
3,552
|
3,279
|
|
|
|
|
營業毛利(千) |
|
6,123
|
4,681
|
117,374
|
6,341
|
6,555
|
5,759
|
96,190
|
|
|
|
|
營業費用(千) |
|
59,995
|
63,828
|
67,647
|
65,146
|
91,821
|
70,183
|
67,399
|
|
|
|
|
營業利益(千) |
|
-53,873 |
-59,147 |
49,727
|
-58,805 |
-85,266 |
-64,424 |
28,791
|
|
|
|
|
營業外收入及支出(千) |
|
29,327
|
-12,823 |
20,070
|
52,639
|
269,417
|
55,870
|
-10,513 |
|
|
|
|
稅前純益(千) |
|
-24,546 |
-71,970 |
69,797
|
-6,166 |
184,151
|
-8,554 |
18,278
|
|
|
|
|
所得稅(千) |
|
110
|
0 |
5,588
|
|
-1,520 |
0 |
8,276
|
|
|
|
|
稅後純益(千) |
|
-24,656 |
-71,970 |
64,209
|
-6,166 |
185,671
|
-8,554 |
10,002
|
|
|
|
|
其他綜合損益(千) |
|
-13,074 |
6,496
|
-8,023 |
-15,869 |
54,671
|
-40,797 |
20,086
|
|
|
|
|
綜合損益(千) |
|
-37,730 |
-65,474 |
56,186
|
-22,035 |
240,342
|
-49,351 |
30,088
|
|
|
|
|
原始每股稅前盈餘(元) |
|
-11.72 |
-0.10 |
0.10
|
-0.01 |
0.26
|
-0.01 |
0.03
|
|
|
|
|
原始每股稅後盈餘(元) |
|
-11.77 |
-0.10 |
0.09
|
-0.01 |
0.26
|
-0.01 |
0.01
|
|
|
|
|
毛利率(%) |
|
58.38
|
54.36
|
96.61
|
63.01
|
76.29
|
61.85
|
96.70
|
|
|
|
|
營業利益率(%) |
|
-513.61 |
-686.88 |
40.93
|
-584.31 |
-992.39 |
-691.91 |
28.94
|
|
|
|
|
稅後純益率(%) |
|
-235.07 |
-835.79 |
52.85
|
-61.27 |
2,160.98
|
-91.87 |
10.06
|
|
|
|
|
稅後權益報酬率(%) |
|
-2.25 |
-6.30 |
5.63
|
-0.55 |
18.30
|
-0.92 |
1.07
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
月營收 |
單月營收(千) |
累計營收(千) |
單月MoM |
單月YoY |
累計YoY |
累計稅前EPS |
備註 |
近3月營收(千) |
近3月年成長 |
|
|
|
|
202504 |
0 |
0 |
0.00
|
0.00
|
0.00
|
|
|
0 |
0 |
|
|
|
|
202503 |
3,279 |
10,880 |
-2.90 |
26.99
|
8.85
|
|
|
10,880
|
8.85 |
|
|
|
|
202502 |
3,377 |
7,601 |
-20.05 |
34.49
|
2.54
|
|
|
11,001
|
6.3 |
|
|
|
|
202501 |
4,224 |
4,224 |
24.24
|
-13.83 |
-13.83 |
|
|
10,778
|
-1.55 |
|
|
|
|
202412 |
3,400 |
150,651 |
7.80
|
15.80
|
22.35
|
-15.66 |
|
10,489
|
22.06 |
|
|
|
|
202411 |
3,154 |
147,251 |
-19.85 |
1.41
|
22.51
|
|
|
10,091
|
30.06 |
|
|
|
|
202410 |
3,935 |
144,097 |
31.08
|
54.50
|
23.07
|
|
|
10,063
|
36 |
|
|
|
|
202409 |
3,002 |
140,162 |
-3.97 |
42.82
|
22.37
|
-3.97 |
|
8,611
|
-7.5 |
|
|
|
|
202408 |
3,126 |
137,160 |
25.90
|
13.67
|
21.99
|
|
|
7,751
|
-42.66 |
|
|
|
|
202407 |
2,483 |
134,034 |
15.92
|
-44.29 |
22.19
|
|
|
119,222
|
16.82 |
|
|
|
|
202406 |
2,142 |
131,551 |
-98.13 |
-66.06 |
25.01
|
30.30
|
|
121,556
|
22.2 |
|
|
|
|
202405 |
114,597 |
129,409 |
2279.01
|
25.54
|
30.82
|
|
創近一年新高 |
121,996
|
28.51 |
|
|
|
|
202404 |
4,817 |
14,812 |
86.56
|
157.32
|
94.00
|
|
|
9,910
|
105.77 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
券商代號 |
券商名稱 |
張增減 |
買張 |
賣張 |
券商代號 |
券商名稱 |
張增減 |
買張 |
賣張 |
|
|
|
|
9600 |
富邦 |
106 |
130 |
24 |
8150 |
台新 |
-122 |
8 |
130 |
|
|
|
|
6160 |
中國信託 |
80 |
101 |
21 |
9100 |
群益金鼎 |
-52 |
0 |
52 |
|
|
|
|
1230 |
彰銀 |
66 |
66 |
0 |
5920 |
元富 |
-38 |
52 |
90 |
|
|
|
|
9300 |
華南永昌 |
30 |
43 |
13 |
7000 |
兆豐 |
-36 |
10 |
46 |
|
|
|
|
9800 |
元大 |
12 |
52 |
40 |
1020 |
合庫 |
-16 |
0 |
16 |
|
|
|
|
1440 |
美林 |
12 |
12 |
0 |
6010 |
奔亞證券 |
-14 |
0 |
14 |
|
|
|
|
1470 |
台灣摩根士丹利 |
9 |
9 |
0 |
1480 |
美商高盛 |
-12 |
0 |
12 |
|
|
|
|
9200 |
凱基 |
4 |
30 |
26 |
1560 |
港商野村 |
-12 |
10 |
22 |
|
|
|
|
9200 |
凱基 |
4 |
30 |
26 |
1030 |
土銀 |
-9 |
0 |
9 |
|
|
|
|
8440 |
摩根大通 |
3 |
9 |
6 |
5380 |
第一金 |
-9 |
9 |
18 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
20250323 |
太景流感新藥 將在陸臨床 |
|
|
|
|
20240813 |
台積電開高5元 台股開盤上漲42點 |
|
|
|
|
20240418 |
太景流感新藥 解盲成功 |
|
|
|
|
20240311 |
太景財報/去年順利轉虧為盈 淨利1.37億元、EPS 0.19元 |
|
|
|
|
20231128 |
防疫概念股帶量衝 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
個股TOP15買賣超券商籌碼統計(20日) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
1日籌碼集中度 |
11.4 |
|
10日籌碼集中度 |
10.8 |
優 |
單日買賣超 |
72 |
|
|
|
5日籌碼集中度 |
8.4 |
|
20日籌碼集中度 |
5.8 |
優 |
累計買賣超 |
-454 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
個股借券統計(20日) |
千張大戶統計(20週) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
單日借賣張數 |
8778 |
借券餘額 |
9237 |
千張大戶戶數 |
38 |
大戶比例 |
54.98 |
|
|
|
|
|
|
|
|
|
|
|
|
更新日期: |
2025/5/2 17:48 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|